Please try another search
By Jonathan Stempel NEW YORK (Reuters) -A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis (SIX:NOVN) of paying illegal kickbacks to doctors to induce...
ZURICH (Reuters) -Swiss pharmaceutical group Novartis (SIX:NOVN) said on Thursday it was winding up MorphoSys sites in Germany and the United States, affecting 330 jobs. Novartis had acquired...
On Wednesday, HSBC announced a downgrade of Novartis (SIX:NOVN) stock from Hold to Reduce, adjusting the price target to CHF82 from the previous CHF95. The decision comes as the pharmaceutical giant...
ZURICH (Reuters) - Novartis (SIX:NOVN) expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals...
Investing.com -- Novartis AG (SIX:NOVN) has raised its annual earnings guidance for the third time, with the drugmaker noting "momentum" in its business and pipeline of medications after it reported...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review